TevraMed Excimer Laser

Introduction

LED 308nm monochromatic phototherapy VS Conventional 311nm UVB phototherapyUVB Phototherapy is the most common and ideal solution to treat vaious autoimmune skin diseases,such as vitiigo, psoriasis, eczema,pityriasis rosea, etc. 308nm is an advanced form of UVB phototherapy that delivers targeted, high-intensity, monochromatic therapeutic ightdirectly work to infected lesion without exposing healthy skin, which can promote a fast clearing and longer remission than traditional 31nmUVB light.
At the same time, clinically proven that LED 308nm UVB make the treatment of vitiigo as fast and effectively as with an excimer system. itssmaller size and lower weight, and easy to use, make it more flexible than excimer laser. With comparably lower price aquisition and nochange of gas ,make it also more cost-effective and affordable than excimer laser.This kind of 308nm uvb phototherapy target lesions precisely and poweru. Especially suitable for localized smal area,or lesion part is lessthan 10% of your whole body, and ealy stage of your skin problem, or noneffective with traditional 311nm uvb phototherapy.

Contraindications
The following patients should not use UV radiation therapy: patients with solar dermatitis, lupus erythematosus, patients with malignant tumors, patients with xeroderma pigmentosum, patients with Bloom syndrome, patients with dermatomyositis, pregnant women and other patients who are not suitable for UV radiation therapy Wait.

Functions 
1. It has the function of minimum erythema test( Test initial treatment dose); 
2. With time treatment function; 
3. It has the function of dose treatment; 
4. With treatment record storage function; 
5. With medical record management function; 
6. With voice prompt function; 
7. With fingerprint recognition function; 

Specification

Application

It is suitable for clinical units or under the guidance of doctors, for skin disease patients to treat
a. vitiligo
b. psoriasis
c. atopic dermatitis
d. mycosis fungoidese. alopecia areata.